Clinical Trial Update: A Comparison of Xalatan (Latanoprost) to Apo-latanoprost and Co-latanoprost in the Treatment of Glaucoma [Phase 4]

View source ↗

Summary

This Phase 4 clinical trial update compares Xalatan (latanoprost) with Apo-latanoprost and Co-latanoprost for glaucoma and ocular hypertension.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ocular Hypertension
• Open-angle Glaucoma

Drugs mentioned

• Apo-latanoprost (latanoprost)
• Co-latanoprost (latanoprost)
• Xalatan (latanoprost)

Snippet

Sponsor: Dr. David Yan | Conditions: POAG, Primary Open Angle Glaucoma | Phase 4 | Status: UNKNOWN